Altis Labs, whose AI model analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, has raised a $25M Series A (Natalie Breymeyer/Axios)
Altis Labs, an AI software company for drug development, raised a $25 million Series A, CEO Felix Baldauf-Lenschen tells Axios Pro.
We haven't written up this one. Techmeme has the full story — the link below goes straight to it.